Compare RDW & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RDW | ATRC |
|---|---|---|
| Founded | 2020 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.5B |
| IPO Year | 2020 | 2005 |
| Metric | RDW | ATRC |
|---|---|---|
| Price | $7.95 | $55.35 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 10 |
| Target Price | $12.72 | ★ $64.89 |
| AVG Volume (30 Days) | ★ 10.6M | 740.8K |
| Earning Date | 11-04-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 2.98 | ★ 74.74 |
| EPS | N/A | ★ 0.27 |
| Revenue | ★ $335,381,000.00 | $201,630,000.00 |
| Revenue This Year | $39.81 | $13.42 |
| Revenue Next Year | $20.36 | $12.24 |
| P/E Ratio | ★ N/A | $215.07 |
| Revenue Growth | 10.29 | ★ 15.40 |
| 52 Week Low | $4.87 | $25.36 |
| 52 Week High | $26.64 | $66.02 |
| Indicator | RDW | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 44.36 | 42.70 |
| Support Level | $7.91 | $55.16 |
| Resistance Level | $10.43 | $61.70 |
| Average True Range (ATR) | 0.69 | 2.86 |
| MACD | 0.01 | -0.66 |
| Stochastic Oscillator | 56.49 | 5.87 |
Redwire Corp is an integrated space and defense technology company focused on technologies including aerospace infrastructure, autonomous systems and multi-domain operations, leveraging digital engineering and artificial intelligence automation. The Company develops and provides mission critical solutions based on space and defense technology platform offerings for government, commercial and civil customers through both short- and long-duration projects. These include technologies and production capability for next-generation spacecraft, large space infrastructure, microgravity capabilities, combat autonomous systems, optical sensors and radio frequency payloads that provide intelligence, surveillance, and reconnaissance capabilities for U.S. and allied nations across multiple domains.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.